Melasma severity scale also showed improvement by the treatment. At 0 weeks, maximum number of patients (65%) reported grade 2 melasma which decreased to 15% after 12 weeks of treatment as more number of patients shifted to grade 1 in which 25% patients were there at baseline that rises to 80% at 12 weeks. Statistically significant difference was seen in grade 2 patients at 8, 10, and 12 weeks (P value < 0.05) and the results remained statistically significant (P value < 0.05) at each follow-up till 24 weeks.